Hypogammaglobulinemia in Multiple Sclerosis Patients Receiving Disease-Modifying Immunomodulatory Agents

被引：0
|
作者：
Tsao, Lulu [1 ]
Otani, Iris M. [2 ]
Bove, Riley [3 ]
机构：
[1] UCSF, Dept Med, San Francisco, CA USA
[2] UCSF, Dept Internal Med, Div Allergy & Immunol, San Francisco, CA USA
[3] UCSF, Dept Neurol, San Francisco, CA USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2019年 / 143卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
49
引用
收藏
页码：AB17 / AB17
页数：1
相关论文
共 50 条
  • [1] Disease-modifying agents in multiple sclerosis
    Coyle, P. K.
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2009, 12 (04) : 273 - 282
  • [2] Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies
    Grebenciucova, Elena
    Pruitt, Amy
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2017, 17 (11)
  • [3] Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies
    Elena Grebenciucova
    Amy Pruitt
    Current Neurology and Neuroscience Reports, 2017, 17
  • [4] Vaccinations in multiple sclerosis patients receiving disease-modifying drugs
    Otero-Romero, Susana
    Ascherio, Alberto
    Lebrun-Frenay, Christine
    CURRENT OPINION IN NEUROLOGY, 2021, 34 (03) : 322 - 328
  • [5] Multiple Sclerosis: Overview of Disease-Modifying Agents
    Finkelsztejn, Alessandro
    PERSPECTIVES IN MEDICINAL CHEMISTRY, 2014, 6 : 65 - 72
  • [6] Factors influencing interruption of disease-modifying agents in multiple sclerosis
    Nociti, V.
    Padua, L.
    Mirabella, M.
    Patanella, A. K.
    Sancricca, C.
    Caggiula, M.
    Frisullo, G.
    Angelucci, E.
    Tonali, P. A.
    Batocchi, A. P.
    JOURNAL OF NEUROLOGY, 2006, 253 : 143 - 143
  • [7] Neutralizing antibodies to disease-modifying agents in the treatment of multiple sclerosis
    Vartanian, TK
    Zamvil, SS
    Fox, E
    Sorensen, PS
    NEUROLOGY, 2004, 63 (11) : S42 - S49
  • [8] Clinical and epidemiological characteristics of multiple sclerosis patients receiving disease-modifying treatment in Poland
    Kapica-Topczewska, Katarzyna
    Collin, Francois
    Tarasiuk, Joanna
    Chorazy, Monika
    Czarnowska, Agata
    Kwasniewski, Miroslaw
    Brola, Waldemar
    Bartosik-Psujek, Halina
    Adamczyk-Sowa, Monika
    Kochanowicz, Jan
    Kulakowska, Alina
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2020, 54 (02) : 161 - 168
  • [9] Adherence to disease-modifying therapies in patients with multiple sclerosis
    Koltuniuk, Aleksandra
    Rosinczuk, Joanna
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 1557 - 1565
  • [10] RACIAL/ETHNIC DIFFERENCE IN THE USE OF DISEASE-MODIFYING AGENTS AMONG PATIENTS WITH MULTIPLE SCLEROSIS
    Cheruvu, S. S.
    Li, J.
    Aparasu, R. R.
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2023, 19 (03): : 564 - 564
12345